Related Experiment Video
Updated: Feb 13, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
Published on: May 16, 2025
Vascular events in autoantibody-defined clusters of SLE: a 12-year prospective cohort study
Sara Ferrigno1,2, Elizabeth V Arkema3, Iva Gunnarsson1
1Division of Rheumatology, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Insights
Systemic lupus erythematosus (SLE) patients have varying cardiovascular and venous thromboembolism risks based on autoantibody profiles. The antiphospholipid antibody (aPL) cluster shows the highest risk, while the autoantibody-negative cluster has the lowest.
Area of Science:
- Rheumatology
- Immunology
- Cardiology
Background:
- Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse clinical manifestations.
- Autoantibody profiles are crucial for understanding SLE heterogeneity and predicting disease outcomes.
- Cardiovascular events and venous thromboembolism are significant morbidities in SLE patients.
Purpose of the Study:
- To investigate the incidence of major cardiovascular events (MACE) and venous thromboembolism (VTE) in SLE patients.
- To stratify SLE patients into four distinct clusters based on 13 autoantibodies.
- To compare vascular event incidence across these SLE autoantibody clusters and matched controls.
Main Methods:
- Prospective cohort study of 461 SLE patients followed for 12.2 years.
- Patients stratified into four baseline autoantibody clusters: Cluster 1 (anti-SSA/SSB), Cluster 2 (anti-nucleosome/Sm/RNP/dsDNA), Cluster 3 (aPL), and Cluster 4 (autoantibody-negative).
- Vascular outcomes (MACE, VTE) prospectively retrieved via National Patient Register; Cox proportional hazards models used for risk estimation against 10 matched controls per patient.
Main Results:
- The antiphospholipid antibody (aPL)-dominated cluster (Cluster 3) exhibited the highest relative risk for MACE (HR 1.91) and VTE (HR 2.69) compared to reference clusters.
- Cluster 2 also showed elevated risks for heart failure and VTE, comparable to Cluster 3, despite patients being younger.
- The autoantibody-negative cluster (Cluster 4) demonstrated the lowest incidence of vascular events among all SLE clusters.
Conclusions:
- Significant differences in MACE and VTE incidence exist among SLE patients categorized by autoantibody profiles.
- The aPL-dominated cluster is associated with the highest risk of major vascular events.
- The autoantibody-negative SLE cluster is linked to the lowest vascular event incidence, highlighting the prognostic value of autoantibody profiling.
Objectives:
We recently identified four SLE clusters based on 13 autoantibodies used in clinical practice. In this prospective cohort study, we investigate the incidence of major cardiovascular events (MACE) and venous thromboembolism (VTE) in SLE patients stratified by clusters. Clusters were compared with each other and to matched controls.
Methods:
Clusters were defined at baseline: cluster 1 dominated by anti-SSA/SSB, cluster 2 by anti-nucleosome/Sm/RNP/dsDNA, cluster 3 by aPL and cluster 4 negative for all 13 autoantibodies. SLE clinical data were collected at enrolment. Vascular outcomes were prospectively retrieved from the National Patient Register using ICD codes. Each patient was matched on birth/sex/residence to 10 controls from the Total Population Register. Subjects with previous vascular events were excluded. Hazard ratios (HRs) and 95% CIs from Cox proportional hazards models estimated the age-adjusted relative risks of incident vascular events.
Results:
We included 461 SLE patients, mean follow-up 12.2 ± 5.6 years. Compared with reference clusters, cluster 3 (n = 154) had the highest relative risk for MACE (HR 1.91 (95% CI: 1.01-3.58)) and VTE (HR 2.69 (95% CI: 1.05-6.9)). Cluster 2 (n = 105) had high risk for heart failure and VTE, similar to cluster 3, despite younger age. The lowest incidence of vascular events was observed in cluster 4 (n = 61) in comparison to the other clusters.
Conclusions:
We observed differences regarding the incidence of MACE and VTE during 12 years of follow-up for four autoantibody-defined clusters. The highest incidences were seen in the aPL-dominated cluster, while the lowest were detected in the autoantibody-negative cluster.
Related Concept Videos
Seedless Vascular Plants
Imaging Studies VII: Vascular Imaging
Defining Psychology
Cluster Sampling Method
To choose a cluster sample, divide the population into clusters (groups) and then randomly select some of the clusters. All the members from these clusters are in the cluster sample. For example, if you randomly sample four departments from your...
Vesicular Tubular Clusters
With the help of motor proteins such...
Integration of Synaptic Events

